Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple SclerosisDavid Baker, Klaus Schmierer|EBioMedicine|2017Cited by 288
Association between pathological and MRI findings in multiple sclerosisMassimo Filippi, Maria A. Rocca, Wolfgang Brück et al.|The Lancet Neurology|2019Cited by 251
Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?João Cerqueira, Jacqueline Palace, D. A. S. Compston et al.|Journal of Neurology Neurosurgery & Psychiatry|2018Cited by 145
Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosisM Wallner-Blazek, Franz Fazekas, Antônio José da Rocha et al.|Journal of Neurology|2013Cited by 85
Aggressive multiple sclerosis (1): Towards a definition of the phenotypeEllen Iacobaeus, Emmanuelle Waubant, Georgina Arrambide et al.|Multiple Sclerosis Journal|2020Cited by 79